mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils

por Rubin-Bejerano, Ifat, Sansal-Castellano, Isabelle, Carlson, Mark, Reznik, Gabriel, Siedlecki, James, Kane, John, Dostalova, Zuzana, Miao, Hua
Publicado 2014

The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody

por Sansal-Castellano, Isabelle, Carlson, Mark, Reznik, Gabriel, Siedlecki, James, Kane, John, Dostalova, Zuzana, Miao, Hua, Rubin-Bejerano, Ifat
Publicado 2015